Hirsutism, Postpartum Telogen Effluvium, and Male Pattern Alopecia

    March 2006 in “ Journal of Cosmetic Dermatology ”
    Larry E. Millikan
    Image of study
    TLDR Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.
    The 2006 document reviews how hormonal changes during and after pregnancy affect hair growth, focusing on conditions such as hirsutism, postpartum telogen effluvium, and male pattern alopecia in women. It explains that hormonal fluctuations can lead to increased hair mass and changes in hair characteristics, with postpartum hair loss typically occurring 3 to 6 months after childbirth due to a large number of hairs entering the telogen phase. Hirsutism may indicate underlying conditions like tumors or polycystic ovaries, while postpartum telogen effluvium is generally self-limiting. Treatment options for postpartum alopecia include minoxidil, but 5 alpha reductase inhibitors are contraindicated for women of childbearing potential. The document also notes the potential benefits of new oral contraceptives and antiandrogen therapy for acne and female alopecia, underscoring the need for patient education and support during these periods of change.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    9 / 9 results